Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 6.33
1.28 %
$ 146 M
Market Cap
-8.79
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Journey Medical Corporation
| Revenue | 56.1 M |
| Cost Of Revenue | 0 |
| Gross Profit | 56.1 M |
| Operating Expenses | 69.8 M |
| Operating Income | -13.7 M |
| Other Expenses | 995 K |
| Net Income | -14.7 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Revenue | 56.1 | 79.2 | 73.7 | 63.1 | 44.5 | 34.9 | 42.3 | 4.5 | 22.6 | 7.3 | 7.3 |
| GROSS PROFIT | |||||||||||
| Cost Of Revenue | 0 | 26.7 | 30.8 | 32.1 | 14.6 | 10.5 | 1.2 | 0 | 0 | 0 | 0 |
| Gross Profit | 56.1 | 52.5 | 42.9 | 31.1 | 29.9 | 24.4 | 41.2 | 4.5 | 22.6 | 7.3 | 7.3 |
| OPERATING INCOME | |||||||||||
| Operating Expenses | 69.8 | 54.6 | 70.4 | 56.4 | 22.1 | 19.1 | 255.1 | 304.9 | 113.2 | 87.1 | 39.0 |
| Selling, General and Administrative Expenses | 40.2 | 43.9 | 59.5 | 39.8 | 22.1 | 19.1 | 172.6 | 71.9 | 30.0 | 17.7 | 8.3 |
| Research and Development Expenses | 9.9 | 7.5 | 10.9 | 16.6 | 0 | 0 | 80.5 | 104.4 | 83.2 | 66.8 | 30.7 |
| Operating Income | (13.7) | (2.1) | (27.5) | (25.3) | 7.9 | 5.3 | (214.0) | (300.3) | (90.6) | (79.8) | (31.7) |
| PRE-TAX INCOME | |||||||||||
| Interest Income Expense | 2.7 | 1.7 | 2.0 | 7.0 | 0.7 | 0.3 | 15.6 | 8.1 | 1.5 | 0.1 | 0.2 |
| Total Other Income | (0.9) | (1.6) | (2.0) | (7.5) | (0.7) | (0.3) | (7.8) | (2.9) | 1.5 | 0.7 | (0.1) |
| Pre-Tax Income | (14.6) | (3.6) | (29.6) | (42.4) | 7.2 | 5.0 | (221.7) | (303.3) | (89.1) | (79.0) | (31.8) |
| NET INCOME | |||||||||||
| Tax Provision | 61 K | 0.2 | 63 K | 1.6 | 1.9 | 1.4 | (0.2) | 5.2 | 3.1 | (0.6) | 31 K |
| Net Income | (14.7) | (3.9) | (29.6) | (44.0) | 5.3 | 3.6 | (221.5) | (303.3) | (89.1) | (78.4) | (31.9) |
| EPS | 0.72 | 0.21 | 1.69 | 2.54 | 0.32 | 0.22 | 5.27 | 7.48 | 2.7 | 2.93 | 4.96 |